Identification of protein kinase CK2 as a potent kinase of Epstein–Barr virus latent membrane protein 1

By Chi L-M.   Yu J-S.   Chang Y-S.  

Biochemical and Biophysical Research Communications, Vol. 294, Iss. 3, 2002-06 ,pp. : 586-591

Elsevier

Access to resources Recommend Favorite

Direct Phage to Intrabody Screening (DPIS): Demonstration by Isolation of Cytosolic Intrabodies Against the TES1 Site of Epstein Barr Virus Latent Membrane Protein 1 (LMP1) that Block NF- B Transactivation

By Gennari F.   Mehta S.   Wang Y.   St. Clair Tallarico A.   Palu G.   Marasco W.A.  

Journal of Molecular Biology, Vol. 335, Iss. 1, 2004-01 ,pp. : 193-207

Elsevier

Access to resources Recommend Favorite

The functional analysis of Epstein-Barr virus latent membrane proteins (LMP1) in patients with lymphoproliferative disorders

By Smirnova K.   Diduk S.   Gurtsevitch V.  

Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry, Vol. 4, Iss. 4, 2010-12 ,pp. : 386-394

MAIK Nauka/Interperiodica

Access to resources Recommend Favorite

Human RPA (hSSB) interacts with EBNA1, the latent origin binding protein of Epstein–Barr virus

By Zhang Dan   Frappier Lori  

Nucleic Acids Research, Vol. 26, Iss. 2, 1998-01 ,pp. : 631-637

Oxford University Press

Access to resources Recommend Favorite

Immunogenicity of a Multiepitope Plasmid DNA Encoding T and B Lymphocyte Epitopes from Latent Membrane Protein 2 (LMP2) of Epstein-Barr Virus as a Vaccine in Mice

By  

Protein and Peptide Letters, Vol. 20, Iss. 10, 2013-10 ,pp. : 1136-1143

Bentham Science Publishers

Access to resources Recommend Favorite